These results are of utmost importance for our understanding of the characteristic dystrophic process in myotonic dystrophy but also in the context of therapeutic development of functional μDys or truncated dystrophins generated by exon-skipping technologies in Duchenne muscular dystrophy. This evidence concerns the gene DMD and myotonic dystrophy.